检索结果 - Sanson, M
- Showing 1 - 20 results of 34
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
P08.63 Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients with recurrent glioblastoma 由 Hottinger, A. F., Sanson, M., Moyal, E., Delord, J., Rezai, K., Leung, A., Perez, S., Bekradda, M., Lachaux, N., Chinot, O.
出版 2016Text -
11
-
12
-
13
-
14
-
15
-
16
P07.15 Diagnostic value of 2-hydroxyglutarate detection by 1H MR spectroscopy in patients with glioma and correlations with tumor phenotype and tissue dosage 由 Di Stefano, A. L., Branzoli, F., Ottolenghi, C., Capelle, L., Mokhtari, K., Villa, C. M., Giry, M., Marjanska, M., Lehericy, S., Sanson, M.
出版 2016Text -
17
-
18
EH1.1 Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion, an int... 由 van den Bent, M. J., Erridge, S., Vogelbaum, M., Nowak, A., Sanson, M., Brandes, A. A., Golfinopoulos, V., Gorlia, T., Kros, J. M., Baumert, B. G.
出版 2016Text -
19
-
20